10x Genomics (TXG) Receives a Buy from Morgan Stanley
Morgan Stanley analyst Tejas Savant maintained a Buy rating on 10x Genomics (TXG – Research Report) today and set a price target of $26.00. The ...
10x Genomics price target lowered to $15 from $18 at Barclays
Barclays lowered the firm’s price target on 10x Genomics (TXG) to $15 from $18 and keeps an Overweight rating on the shares.Maximize Your ...
News Medical20h
Leveling up NGS workflows with INTEGRA Biosciences’ solutions
INTEGRA Biosciences offers liquid handling solutions and magnetic modules to streamline every stage of NGS sample preparation ...
News Medical23h
Addressing the global challenge of bacterial STIs
According to the World Health Organization (WHO), hundreds of millions of new cases of bacterial sexually transmitted ...